<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The beta2-microglobulin/HLA deficient Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line Daudi was tested for sensitivity to EBV-specific cytotoxicity mediated by natural killer (NK)-depleted T-cells from <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">mononucleosis</z:e> patients </plain></SENT>
<SENT sid="1" pm="."><plain>While the Daudi line was not as sensitive as the reference EBV-genome-positive target line, it was clearly sensitive in the majority of cases </plain></SENT>
<SENT sid="2" pm="."><plain>This would speak against a major role of syngeneic restriction in this system </plain></SENT>
</text></document>